Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
Micromet Closes $80.5 Million Public Offering of Common Stock
Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab
National Institutes of Health Chooses Web of Science(R) to Power electronic Scientific Portfolio Assistant (eSPA)
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.